Stock MJN PHARMACAN CAPITAL CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News PharmaCan Capital Corp Toronto S.E.

Equities

MJN

CA7171151094

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for PharmaCan Capital Corp
May. 28 Cronos Group Ends Sale-Leaseback Deal with Future Farmco, Continues to Explore Options for Peace Naturals Campus MT
May. 28 Cronos Group Fluctuating in U.S. After Hours As Terminates Sale-Leaseback of Peace Naturals Campus MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
GL
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
AQ
Cronos Group Ends Sale-Leaseback Deal with Future Farmco, Continues to Explore Options for Peace Naturals Campus
MT
Cronos Group Fluctuating in U.S. After Hours As Terminates Sale-Leaseback of Peace Naturals Campus
MT
Cronos Terminates Sale-Leaseback of Peace Naturals Campus
GL
Cronos Group Inc. Terminates Sale-Leaseback of Peace Naturals Campus
CI
Future Farmco Canada Inc. cancelled the acquisition of Peace Naturals Project Inc. from Cronos Group Inc..
CI
Cronos : 2024 – Q1 Transcript
PU
Pot stocks rise as US unveils proposal to ease restrictions on marijuana
RE
US Government Reclassifies Marijuana to Less-Restrictive Category
MT
Justice Department Set to Post Cannabis Reclassification Plans
MT
CIBC Adjusts Cronos Group Price Target to $3.50 From $3, Maintains Outperform Rating
MT
Cronos Shares Jump as Q1 Loss Narrows, Revenue Rises
MT
Cronos Group Up 3.9% in U.S. Premarket Trade as Q1 Loss Narrows on Higher Sales
MT
Transcript : Cronos Group Inc., Q1 2024 Earnings Call, May 09, 2024
Cronos: Q1 Earnings Snapshot
AQ
Cronos Group Brief: Q1 Net Loss $2.484 Million
MT
Cronos Group Brief: Citing Balance Sheet with US$855 Million in Cash and Cash Equivalents
MT
Cronos Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Cronos Group Brief: Q1 Consolidated net revenue US$25.288 Million
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRON Stock
  4. MJN Stock
  5. News PharmaCan Capital Corp